Short Interest in Sanofi (OTCMKTS:SNYNF) Drops By 59.9%

Sanofi (OTCMKTS:SNYNF) was the recipient of a large decline in short interest during the month of July. As of July 31st, there was short interest totaling 85,443 shares, a decline of 59.9% from the July 15th total of 212,880 shares. Based on an average daily volume of 133,967 shares, the days-to-cover ratio is currently 0.6 days.

Sanofi Trading Up 1.1%

Shares of Sanofi stock opened at $88.10 on Friday. Sanofi has a 12-month low of $80.74 and a 12-month high of $106.34. The business’s 50 day moving average is $86.32 and its 200-day moving average is $89.54.

About Sanofi

Sanofi is a multinational biopharmaceutical company headquartered in Paris, France, specializing in the research, development and manufacturing of prescription medicines, vaccines and consumer healthcare products. With a strategic focus on specialty care, vaccines, and general medicines, Sanofi’s portfolio addresses a broad range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology and rare diseases. The company operates through distinct business segments, each dedicated to advancing patient care through innovative therapies and preventive solutions.

In its pharmaceuticals segment, Sanofi develops and markets biologics and small molecules designed to treat chronic and acute conditions.